Newly diagnosed papillary craniopharyngioma with BRAF V600E mutation treated with single-agent selective BRAF inhibitor dabrafenib: a case report

We report a case of a patient with newly diagnosed, locally extensive and cystic, suprasellar papillary craniopharyngioma successfully treated with single-agent Dabrafenib. The patient was symptomatic with gait imbalance with falls, lethargic episodes, fatigue and incontinence. Diagnostic imaging de...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, Mayank, Bhattacharjee, Meenakshi, Shepard, Scott, Hsu, Sigmund
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800270/
https://www.ncbi.nlm.nih.gov/pubmed/31666933
http://dx.doi.org/10.18632/oncotarget.27203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800270/
https://www.ncbi.nlm.nih.gov/pubmed/31666933
http://dx.doi.org/10.18632/oncotarget.27203

Ejemplares similares